Founded in 2002, LabConnect provides global central laboratory services including routine and esoteric laboratory testing, kit building, sample management and tracking, biostorage and scientific support services for biopharmaceutical and CRO clients. LabConnect currently has locations worldwide and central laboratory capabilities on six continents. LabConnect’s service suite includes: Specialized Testing. With more than 4,000 validated tests across our network, LabConnect can handle everything from general safety testing to the most complex molecular diagnostics and biomarker analyses. Specimen Tracking. LabConnect’s real-time specimen tracking service, SampleGISTICS™, follows the clients’ specimen samples from collection through logistics to receipt at any lab or storage location in the world.a

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMACY MARKET

VENENO TECHNOLOGIES, A NOVEL DRP DRUG DISCOVERY COMPANY, RAISES $2MILLION (¥200M YEN) IN SEED FUNDING ROUND

Veneno Technologies Co. Ltd. | January 27, 2022

news image

Veneno Technologies Co. Ltd. is pleased to announce that it has completed fundraising of 200 million yen through a third-party allocation of new shares to SBI Investment Co., Ltd., Tsukuba Institute of Research, Ltd., and SBI regional activation support Co., Ltd. The funds raised will be used to strengthen the recruitment and organizational structure, to further develop the Company's proprietary peptide drug discovery platform technology, and invest in the research and develop...

Read More

BUSINESS INSIGHTS

LIFESPIN LAUNCHES COMMERCIAL ACCESS TO ITS METABOLIC PROFILER SOFTWARE AND DATABASE FOR PHARMA AND BIOBANK SERVICES

Lifespin | September 16, 2022

news image

Lifespin GmbH, based in Regensburg with offices in Boston, Massachusetts, announced that it has launched a new commercial service that, for the first time, will provide the pharmaceutical and biobanking industry with access to Lifespin’s proprietary metabolic database, along with its advanced interpretive software to assist in various phases of drug research, development, and manufacturing. Immediate applications of Lifespin’s commercial services will include quality c...

Read More

BUSINESS INSIGHTS

SIMULATIONS PLUS ENTERS NEW COLLABORATION TO ENHANCE MACHINE LEARNING MODELS FOR IONIZATION CONSTANTS (PKA)

Simulations Plus, Inc. | August 08, 2022

news image

Simulations Plus, Inc. a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced it has entered a new collaboration with a large pharmaceutical company to extend the industry’s top-rated machine learning models for the prediction of ionization constants (pKa) in the ADMET Predictor® platform. In this collaboration, the partner company will contribute tens of thousands of proprietary pKa measurements. The t...

Read More

PHARMACY MARKET

RX-360 LAUNCHES NEW AUDITSPLUS®

Rx-360 | June 10, 2021

news image

Rx-360, a global pharmaceutical consortium committed to supply chain integrity and patient safety, is happy to announce the extension of our Audit Program. The release of the new Rx-360 auditsPlus database is the key driver of this growth. This interactive, user-friendly database will not only raise awareness of the Rx-360 Joint Audit Program®. Still, it will also provide Rx-360 program users with new and improved tools to minimize their audit burden. Rx-360's CEO, Jim Fri...

Read More
news image

PHARMACY MARKET

VENENO TECHNOLOGIES, A NOVEL DRP DRUG DISCOVERY COMPANY, RAISES $2MILLION (¥200M YEN) IN SEED FUNDING ROUND

Veneno Technologies Co. Ltd. | January 27, 2022

Veneno Technologies Co. Ltd. is pleased to announce that it has completed fundraising of 200 million yen through a third-party allocation of new shares to SBI Investment Co., Ltd., Tsukuba Institute of Research, Ltd., and SBI regional activation support Co., Ltd. The funds raised will be used to strengthen the recruitment and organizational structure, to further develop the Company's proprietary peptide drug discovery platform technology, and invest in the research and develop...

Read More
news image

BUSINESS INSIGHTS

LIFESPIN LAUNCHES COMMERCIAL ACCESS TO ITS METABOLIC PROFILER SOFTWARE AND DATABASE FOR PHARMA AND BIOBANK SERVICES

Lifespin | September 16, 2022

Lifespin GmbH, based in Regensburg with offices in Boston, Massachusetts, announced that it has launched a new commercial service that, for the first time, will provide the pharmaceutical and biobanking industry with access to Lifespin’s proprietary metabolic database, along with its advanced interpretive software to assist in various phases of drug research, development, and manufacturing. Immediate applications of Lifespin’s commercial services will include quality c...

Read More
news image

BUSINESS INSIGHTS

SIMULATIONS PLUS ENTERS NEW COLLABORATION TO ENHANCE MACHINE LEARNING MODELS FOR IONIZATION CONSTANTS (PKA)

Simulations Plus, Inc. | August 08, 2022

Simulations Plus, Inc. a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced it has entered a new collaboration with a large pharmaceutical company to extend the industry’s top-rated machine learning models for the prediction of ionization constants (pKa) in the ADMET Predictor® platform. In this collaboration, the partner company will contribute tens of thousands of proprietary pKa measurements. The t...

Read More
news image

PHARMACY MARKET

RX-360 LAUNCHES NEW AUDITSPLUS®

Rx-360 | June 10, 2021

Rx-360, a global pharmaceutical consortium committed to supply chain integrity and patient safety, is happy to announce the extension of our Audit Program. The release of the new Rx-360 auditsPlus database is the key driver of this growth. This interactive, user-friendly database will not only raise awareness of the Rx-360 Joint Audit Program®. Still, it will also provide Rx-360 program users with new and improved tools to minimize their audit burden. Rx-360's CEO, Jim Fri...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us